Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997
- PMID: 9647466
- PMCID: PMC1565402
- DOI: 10.1038/sj.bjp.0701813
Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997
Abstract
1. The nonpeptide bradykinin (BK) B2 receptor antagonist, FR165649 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl)cinnamidoacetyl ]-N-methylamino]benzyloxy]-2-methylquinoline), and agonist, FR190997 (8-[2,6-dichloro-3-[N-[(E)-4-(N-methylcarbamoyl) cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridyl methoxy)quinoline) have been identified. These compounds have a common chemical structure, and the 2-pyridylmethoxy group is the only structural difference between them. 2. Both FR165649 and FR190997 displaced [3H]-BK binding to B2 receptors in guinea-pig ileum membranes, with an IC50 of 4.7 x 10(-10) M and 1.5 x 10(-9) M, respectively. They also displaced [3H]-BK binding to B2 receptors in human lung fibroblast IMR-90 cells, with an IC50 of 1.6 x 10(-9) M and 9.8 x 10(-10) M, respectively. 3. In guinea-pig isolated ileum-preparations, FR165649 had no agonistic effect on contraction and caused parallel rightward shifts of the concentration-response curves to BK on contraction. Analysis of the data produced a nominal pA2 value of 9.2+/-0.1 (n=5) and a slope of 1.4+/-0.1 (n=5). On the other hand, FR190997 induced concentration-dependent contraction of guinea-pig ilea with a pD2 of 7.9+/-0.2 and the contraction was inhibited by a specific peptide bradykinin B2 receptor antagonist, Hoe 140 (D-Arg-[Hyp3, Thi5, D-Tic7, Oic8]BK) in a non-competitive manner. 4. In IMR-90 cells, FR165649 had no agonistic effect on phosphatidyl inositol (PI) hydrolysis and caused parallel rightward shifts (approximately 200 fold shift at 10(-7) M) of the concentration-response curves to BK on PI hydrolysis. FR190997 induced concentration-dependent PI hydrolysis in IMR-90 cells with a pD2 of 8.4+/-0.1, and this effect was inhibited by Hoe 140. 5. These results indicate that FR165649 and FR190997 are, respectively, a potent bradykinin B2 receptor antagonist and agonist, and that the agonistic activity depends on the small part of the nonpeptide ligand. FR165649 and FR190997 may be useful tools for studying the relationship between ligands and receptors.
Similar articles
-
The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.Br J Pharmacol. 1997 Feb;120(4):617-24. doi: 10.1038/sj.bjp.0700955. Br J Pharmacol. 1997. PMID: 9051299 Free PMC article.
-
Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.Br J Pharmacol. 1997 Jun;121(3):469-76. doi: 10.1038/sj.bjp.0701159. Br J Pharmacol. 1997. PMID: 9179388 Free PMC article.
-
Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.Eur J Pharmacol. 2000 Dec 8;409(2):185-94. doi: 10.1016/s0014-2999(00)00850-5. Eur J Pharmacol. 2000. PMID: 11104833
-
Bradykinin receptor types and B2 subtypes.Life Sci. 1994;55(10):735-49. doi: 10.1016/0024-3205(94)00557-5. Life Sci. 1994. PMID: 8072371 Review.
-
Discovery of orally active nonpeptide bradykinin B2 receptor antagonists.Immunopharmacology. 1999 Sep;43(2-3):163-8. doi: 10.1016/s0162-3109(99)00131-9. Immunopharmacology. 1999. PMID: 10596849 Review.
Cited by
-
Hypothesized and found mechanisms for potentiation of bradykinin actions.Signal Transduct. 2006 Feb;6(1):5-18. doi: 10.1002/sita.200500061. Epub 2006 Jan 17. Signal Transduct. 2006. PMID: 32327962 Free PMC article.
-
Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.ACS Pharmacol Transl Sci. 2020 Nov 5;3(6):1391-1421. doi: 10.1021/acsptsci.0c00137. eCollection 2020 Dec 11. ACS Pharmacol Transl Sci. 2020. PMID: 33344909 Free PMC article.
-
Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.Br J Pharmacol. 2001 Aug;133(8):1296-306. doi: 10.1038/sj.bjp.0704208. Br J Pharmacol. 2001. PMID: 11498515 Free PMC article.
-
Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9alpha.Peptides. 2005 Jul;26(7):1235-47. doi: 10.1016/j.peptides.2005.03.046. Epub 2005 Apr 25. Peptides. 2005. PMID: 15949642 Free PMC article.
-
Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.J Pharmacol Exp Ther. 2013 Oct;347(1):100-16. doi: 10.1124/jpet.113.206896. Epub 2013 Jul 26. J Pharmacol Exp Ther. 2013. PMID: 23892571 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous